Vuk Stambolic

14.3k total citations · 6 hit papers
85 papers, 10.8k citations indexed

About

Vuk Stambolic is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Vuk Stambolic has authored 85 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 38 papers in Oncology and 16 papers in Cell Biology. Recurrent topics in Vuk Stambolic's work include PI3K/AKT/mTOR signaling in cancer (35 papers), Metabolism, Diabetes, and Cancer (31 papers) and Cancer-related Molecular Pathways (22 papers). Vuk Stambolic is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (35 papers), Metabolism, Diabetes, and Cancer (31 papers) and Cancer-related Molecular Pathways (22 papers). Vuk Stambolic collaborates with scholars based in Canada, United States and United Kingdom. Vuk Stambolic's co-authors include James R. Woodgett, Tak W. Mak, Laurent Ruel, Akira Suzuki, Pamela J. Goodwin, Ryan J.O. Dowling, Takehiko Sasaki, José Luís de la Pompa, Jürgen Ruland and Josef Penninger and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Vuk Stambolic

82 papers receiving 10.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN

1998 2.1k citations Vuk Stambolic, Akira Suzuki et al. Cell profile →
Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells

1996 1.2k citations Vuk Stambolic, Laurent Ruel et al. Current Biology profile →
Regulation of PTEN Transcription by p53

2001 753 citations Vuk Stambolic, David MacPherson et al. Molecular Cell profile →
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice

1998 665 citations Akira Suzuki, José Luís de la Pompa et al. Current Biology profile →
Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation

1994 516 citations Vuk Stambolic, James R. Woodgett profile →
Deletion of Pten in mouse brain causes seizures, ataxia and defects in soma size resembling Lhermitte-Duclos disease

2001 399 citations Vuk Stambolic, Akira Suzuki et al. profile →

Peers

Countries citing papers authored by Vuk Stambolic

Since Specialization

Citations

This map shows the geographic impact of Vuk Stambolic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vuk Stambolic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vuk Stambolic more than expected).

Fields of papers citing papers by Vuk Stambolic

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vuk Stambolic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vuk Stambolic. The network helps show where Vuk Stambolic may publish in the future.

Co-authorship network of co-authors of Vuk Stambolic

This figure shows the co-authorship network connecting the top 25 collaborators of Vuk Stambolic. A scholar is included among the top collaborators of Vuk Stambolic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vuk Stambolic. Vuk Stambolic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	β-catenin turnover is regulated by Nek10-mediated tyrosine phosphorylation in A549 lung adenocarcinoma cells 2024 ·Proceedings of the National Academy of Sciences ·Previn Dutt, (unknown), (unknown), (unknown), Vuk Stambolic	3
2	Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer 2023 ·Journal of Clinical Oncology ·Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Judith M. Bliss, Priya Rastogi, Manuela Rabaglio, Alastair M. Thompson, Daniel Rea, (unknown), Lois E. Shepherd, Vuk Stambolic, Wendy R. Parulekar	11
3	Machine learning-enabled cancer diagnostics with widefield polarimetric second-harmonic generation microscopy 2022 ·Scientific Reports ·(unknown), (unknown), (unknown), Ahmad Golaraei, (unknown), Lukas Kontenis, Susan J. Done, Edvardas Žurauskas, Vuk Stambolic, Brian C. Wilson, Virginijus Barzda	17
4	The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer 2021 ·Cell Death and Differentiation ·C. Bassi, Jérôme Fortin, Bryan E. Snow, Andrew Wakeham, Jason Ho, Jillian Haight, Annick You-Ten, (unknown), (unknown), Chiara Gorrini, Vuk Stambolic, Tak W. Mak	21
5	Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo 2021 ·JNCI Cancer Spectrum ·Pamela J. Goodwin, Ryan J.O. Dowling, Marguerite Ennis, Bingshu E. Chen, Wendy R. Parulekar, Lois E. Shepherd, Karen A. Gelmon, Timothy J. Whelan, Jennifer A. Ligibel, Dawn L. Hershman, Ingrid A. Mayer, Timothy J. Hobday, Priya Rastogi, Manuela Rabaglio, Julie Lemieux, Alastair M. Thompson, Daniel Rea, Vuk Stambolic	12
6	Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study 2020 ·npj Breast Cancer ·Mitchell J. Elliott, Marguerite Ennis, Kathleen I. Pritchard, Carol Townsley, (unknown), Christine Elser, Eitan Amir, Philippe L. Bédard, Lakshmi Rao, Vuk Stambolic, Srikala S. Sridhar, Pamela J. Goodwin, David W. Cescon	9
7	PTEN Nuclear Functions 2019 ·Cold Spring Harbor Perspectives in Medicine ·Jason Ho, (unknown), Ryan J.O. Dowling, Vuk Stambolic	46
8	A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy 2019 ·The Breast ·Isabel Pimentel, Ana Elisa Lohmann, Marguerite Ennis, Ryan J.O. Dowling, David W. Cescon, Christine Elser, Kylea Potvin, Rashida Haq, Caroline Hamm, Martin C. Chang, Vuk Stambolic, Pamela J. Goodwin	73
9	mTORC1 and CK2 coordinate ternary and eIF4F complex assembly 2016 ·Nature Communications ·Valentina Gandin, Laìa Masvidal, Marie Cargnello, Laszlo Gyenis, Shannon McLaughlan, Yutian Cai, (unknown), Masahiro Morita, Preetika Balanathan, Olivier Jean‐Jean, Vuk Stambolic, Matthias Trost, Luc Furic, Louise Larose, Antonis E. Koromilas, Katsura Asano, David W. Litchfield, Ola Larsson, Ivan Topisirović	73
10	Characterization of nuclear PTEN and its post translational modifications 2015 ·Methods ·Jason Ho, C. Bassi, Vuk Stambolic	11
11	Nuclear PTEN Controls DNA Repair and Sensitivity to Genotoxic Stress 2013 ·Science ·C. Bassi, Jason Ho, Tharan Srikumar, Ryan J.O. Dowling, Chiara Gorrini, S.J. Miller, Tak W. Mak, Benjamin G. Neel, Brian Raught, Vuk Stambolic	322
12	Metformin in cancer: translational challenges 2012 ·Journal of Molecular Endocrinology ·Ryan J.O. Dowling, Saroj Niraula, Vuk Stambolic, Pamela J. Goodwin	278
13	Characterization of the Intrinsic and TSC2-GAP–Regulated GTPase Activity of Rheb by Real-Time NMR 2009 ·Science Signaling ·Christopher B. Marshall, Jason Ho, Claudia Buerger, Michael J. Plevin, Guangyao Li, Zhihong Li, Mitsuhiko Ikura, Vuk Stambolic	54
14	The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization 2008 ·Proceedings of the National Academy of Sciences ·Fatemeh Fouladkou, (unknown), Hiroshi Kawabe, Antje Neeb, Lu Chen, Nils Brose, Vuk Stambolic, Daniela Rotin	145
15	Functional distinctions of protein kinase B/Akt isoforms defined by their influence on cell migration 2006 ·Trends in Cell Biology ·Vuk Stambolic, James R. Woodgett	146
16	Chk2 regulates irradiation-induced, p53-mediated apoptosis in Drosophila 2002 ·Proceedings of the National Academy of Sciences ·Malte Peters, Carmela DeLuca, Atsushi Hirao, Vuk Stambolic, Julia M. Potter, Lily Zhou, (unknown), Bryan E. Snow, Sudha Arya, (unknown), Denis Bouchard, Richard Binari, Armen S. Manoukian, Tak W. Mak	78
17	Regulation of PTEN Transcription by p53 breakdown → 2001 ·Molecular Cell ·Vuk Stambolic, David MacPherson, (unknown), Yunping Lin, Brian J. Snow, (unknown), Samuel Benchimol, Tak W. Mak	753
18	Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN breakdown → 1998 ·Cell ·Vuk Stambolic, Akira Suzuki, José Luís de la Pompa, Greg M. Brothers, Christine Mirtsos, Takehiko Sasaki, Jürgen Ruland, Josef Penninger, David P. Siderovski, Tak W. Mak	2061
19	Genetic analysis of protein kinase B (AKT) in Drosophila 1998 ·Current Biology ·Brian E. Staveley, Laurent Ruel, Jing Jin, Vuk Stambolic, Fabrizio G. Mastronardi, Pascal Heitzler, James R. Woodgett, Armen S. Manoukian	118
20	Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells breakdown → 1996 ·Current Biology ·Vuk Stambolic, Laurent Ruel, James R. Woodgett	1151

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact